Oppenheimer Maintains Outperform on MediWound, Lowers Price Target to $32

Benzinga Newsdesk www.benzinga.com Negative 94.5%

Neg 94.5% Neu 0% Pos 0%

Oppenheimer analyst Francois Brisebois maintains MediWound (NASDAQ:MDWD) with a Outperform and lowers the price target from $33 to $32.